Legend Biotech Corporation (LEGN)
NASDAQ
LEGN price, last 12 months
Key stats
- Previous close
- $16.25
- Open
- $16.30
- Day range
- $15.73 – $16.42
- 52-week range
- $15.15 – $37.50
- Volume
- 2.4M
- Avg volume (20 days)
- 2.7M
- Market cap
- $3.4B
Performance
Technicals and fundamentals
About Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
- Listed on
- NASDAQ
- Market cap
- $3.4B